Department of Pharmaceutical Sciences, University of Eastern Piedmont, Novara, Italy.
Department of Sciences and Drug Technology, University of Turin, Torino, Italy.
FEBS Lett. 2023 Aug;597(16):2119-2132. doi: 10.1002/1873-3468.14680. Epub 2023 Jun 15.
Mycobacterium tuberculosis (MTB) is the etiologic agent of tuberculosis (TB), an ancient disease which causes 1.5 million deaths worldwide. Dihydroorotate dehydrogenase (DHODH) is a key enzyme of the MTB de novo pyrimidine biosynthesis pathway, and it is essential for MTB growth in vitro, hence representing a promising drug target. We present: (i) the biochemical characterization of the full-length MTB DHODH, including the analysis of the kinetic parameters, and (ii) the previously unreleased crystal structure of the protein that allowed us to rationally screen our in-house chemical library and identify the first selective inhibitor of mycobacterial DHODH. The inhibitor has fluorescence properties, potentially instrumental to in cellulo imaging studies, and exhibits an IC value of 43 μm, paving the way to hit-to-lead process.
结核分枝杆菌(MTB)是结核病(TB)的病原体,这是一种古老的疾病,在全球范围内导致 150 万人死亡。二氢乳清酸脱氢酶(DHODH)是 MTB 从头嘧啶生物合成途径中的关键酶,对 MTB 的体外生长至关重要,因此是一个有前途的药物靶点。我们介绍了:(i)全长 MTB DHODH 的生化特性,包括对动力学参数的分析,以及(ii)该蛋白的以前未发布的晶体结构,使我们能够合理筛选我们的内部化学库,并鉴定出第一个分枝杆菌 DHODH 的选择性抑制剂。该抑制剂具有荧光特性,对细胞内成像研究可能具有重要作用,其 IC 值为 43μm,为从苗头化合物到先导化合物的发展铺平了道路。